I have found with bio techs at this point of the trial time that the market is usually very cautious to the extreme that they will actually price in failure.
So that IF and when they do announce a positive endpoint that's when you get the ''binerary effect'' in the share price regardless of what situation the general market is in.
Just my opinion here and DYOR.
News: ATX Amplia Therapeutics Says Approval From Korean Regulator, page-8
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
18.5¢ |
Change
0.010(5.71%) |
Mkt cap ! $89.99M | |||
| Open | High | Low | Value | Volume |
| 18.0¢ | 19.0¢ | 17.0¢ | $1.746M | 9.554M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 196996 | 18.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 19.0¢ | 287768 | 7 |
View Market Depth
| Last trade - 16.10pm 07/08/2025 (20 minute delay) ? |
| ATX (ASX) Chart |